Location Seattle, Washington, United States Regions Greater Seattle Area, West Coast, Western US Gender Male
Developer of discovery platforms designed to find rare, disease-fighting antibodies possessing characteristics for therapeutic or diagnostic applications using a unifying concept of efficient host immune repertoire sampling of mother nature's vastly complex pool of antibodies and their natural heavy and light chain pairs. Validation of this
concept is seen in the results of my founding of Theraclone-Sciences (fka Spaltudaq) which has two antibodies in clinical trials, a four target deal with Pfizer, flu collaboration with Zinyaku Kogyo, an impressive HIV relationship with IAVI, and is now going to be publicly traded; the founding of North Coast and V-Gene, Inc. where corporate relationships have led to antibody clinical lead candidates.
